Clinical performance of the STANDARD M10 SARS‐CoV‐2 rapid RT‐PCR assay in patients visiting an emergency department

Author:

Lee Dong‐hyun1ORCID,Han Eunhee2ORCID,Ryu Soorack3ORCID,Choi Hyuk joong4ORCID,Kim Jieun5ORCID,Kim Jinyeong6ORCID,Bae Mi Hyun7ORCID

Affiliation:

1. Department of Laboratory Medicine Gyeongsang National University Hospital Jinju South Korea

2. Department of Laboratory Medicine, Daejeon St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul South Korea

3. Biostatistical Consulting and Research Laboratory, Medical Research Collaborating Center Hanyang University Seoul South Korea

4. Department of Emergency Medicine, Hanyang University Guri Hospital Hanyang University College of Medicine Guri South Korea

5. Department of Internal Medicine, Division of Infectious Disease, Hanyang University Guri Hospital Hanyang University College of Medicine Guri South Korea

6. Department of Internal Medicine, Division of Infectious Disease Hanyang University Guri Hospital Guri South Korea

7. Department of Laboratory Medicine, Hanyang University Guri Hospital Hanyang University College of Medicine Guri South Korea

Abstract

AbstractIn emergency departments, rapid screening of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was important for arranging limited isolation resources and patient care during the coronavirus disease 2019 (COVID‐19) pandemic. STANDARD M10 SARS‐CoV‐2 (SD Biosensor) is a recently developed cartridge‐based RT‐PCR that provides a turnaround time of 1 h, which is shorter than that for conventional RT‐PCR. This study evaluated the clinical performance of STANDARD M10 in patients visiting an emergency department. From March to June 2022, two specimens were collected from patients visiting an emergency department. Each specimen comprised one nasopharyngeal and one oropharyngeal swab. Respective specimens underwent rapid RT‐PCR using STANDARD M10 and conventional RT‐PCR using Allplex SARS‐CoV‐2 (Seegene). When discordant results occurred, specimens undergoing the STANDARD M10 were retested with the Allplex to exclude specimen variations. Retest results replaced initial results of the Allplex. Clinical performance of STANDARD M10 was compared with Allplex. The study enrolled 1971 patients. COVID‐19 prevalence was 6.2% based on the Allplex. Compared with the Allplex, overall agreement, positive percent agreement, and negative percent agreement of STANDARD M10 were 99.5% (95% CI: 99.1%–99.8%), 95.9% (95% CI: 90.8%–98.3%), and 99.8% (95% CI: 99.4%–99.9%), respectively. Nine discordant results were all positive on droplet digital PCR, except for one specimen that was positive with STANDARD M10. The STANDARD M10 showed reliable diagnostic performance for detecting SARS‐CoV‐2 from patients visiting in emergency departments and is a useful tool in emergency healthcare systems because of its easy‐to‐use cartridge‐based assay and short resulting time for detecting SARS‐CoV‐2.

Publisher

Wiley

Subject

Infectious Diseases,Virology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3